Megan M Simonds
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 07, 2026
Soluble factors released from fibroblast-like synoviocytes of JIA patients with future extended course can condition persistent JIA synovial fibroblasts for increased IL-6 production.Megan M Simonds, Lina Al-Jaberi, Hermine I Brunner
|Jan 03, 2024
Methotrexate inhibits BMP4 and abrogates the hypertrophic chondrocyte phenotype of synovial fibroblasts in juvenile idiopathic arthritis.Megan M Simonds, Samuel T Freer, Anne Marie C Brescia
|Dec 09, 2023
Adalimumab Effectively Decreases Inflammation Downstream of TNFα Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis.Megan M Simonds, Samuel T Freer, Lina Al-Jaberi
|Nov 07, 2022
CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment.Lina Al-Jaberi, Megan M Simonds, Anne Marie C Brescia
|May 13, 2021
The culture microenvironment of juvenile idiopathic arthritis synovial fibroblasts is favorable for endochondral bone formation through BMP4 and repressed by chondrocytes.Megan M Simonds, Amanda R Schlefman, Suzanne M McCahan
|Nov 17, 2020
Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation.Megan M Simonds, Amanda R Schlefman, Suzanne M McCahan
Pageof 1
